Money Matters
-
Using Leftover Cancer Drugs to Help OthersCancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.
by Jon Kelvey
-
Caregiving With Confidence
Take Financial InventoryTreatment-related expenses can increase stress on both caregivers and patients. Learning to talk about these concerns may help ease the burden.
by Aimee Swartz
-
Forward Look
Medicare to Cover CAR-T Cell TherapyHigh cost may still limit access.
by Nancy Averett
-
Despite Generic Imatinib, Cost of Treating CML Remains HighThe arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.
by Anna Azvolinsky
-
From the Editor-in-Chief
Value-Based Cancer Care: Paying for PerformanceThe Centers for Medicare & Medicaid Services implements incentive programs to reward quality care.
by William G. Nelson, MD, PhD
-
Clinical Trials: An African American Survivor’s ExperienceMelvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.
by Melvin Mann
-
Food Insecurity and CancerAfter discovering that some patients weren't able to access the food they needed, a community oncology practice partnered with a local food bank.
by Jen Tota McGivney
-
How Disability Insurers Monitor Patients OnlineCompanies that offer disability insurance may monitor patients' social media accounts to determine if they qualify for the benefits being received.
by Kate Yandell
-
The Right DoseResearchers want to find out when cancer patients can benefit from receiving lower doses of drugs or radiation, shortening treatment or skipping certain treatments altogether.
by Kate Yandell
-
Focusing on Proton TherapyProton therapy, an alternative to standard radiation therapy, is safe and effective. But evidence is lacking that it's always a better option than standard radiation, and some insurers balk at the higher price tag.
by Sue Rochman
